124 related articles for article (PubMed ID: 37651830)
21. Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9.
Maierhof SK; Schinke C; Cernoch J; Hew L; Bruske LP; Fernandez Vallone V; Fischer K; Stachelscheid H; Huehnchen P; Endres M; Diecke S; Telugu NS; Boehmerle W
Stem Cell Res; 2023 Dec; 73():103253. PubMed ID: 37984032
[TBL] [Abstract][Full Text] [Related]
22. Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.
Xu X; Tay Y; Sim B; Yoon SI; Huang Y; Ooi J; Utami KH; Ziaei A; Ng B; Radulescu C; Low D; Ng AYJ; Loh M; Venkatesh B; Ginhoux F; Augustine GJ; Pouladi MA
Stem Cell Reports; 2017 Mar; 8(3):619-633. PubMed ID: 28238795
[TBL] [Abstract][Full Text] [Related]
23. Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A
Ge N; Liu M; Li R; Allen NM; Galvin J; Shen S; O'Brien T; Prendiville TW
Stem Cell Rev Rep; 2023 Nov; 19(8):2774-2789. PubMed ID: 37653182
[TBL] [Abstract][Full Text] [Related]
24. Genome Editing in Human Induced Pluripotent Stem Cells (hiPSCs).
Higo S; Hikoso S; Miyagawa S; Sakata Y
Methods Mol Biol; 2021; 2320():235-245. PubMed ID: 34302662
[TBL] [Abstract][Full Text] [Related]
25. FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells.
Caillaud A; Lévêque A; Thédrez A; Girardeau A; Canac R; Bray L; Baudic M; Barc J; Gaborit N; Lamirault G; Gardie B; Idriss S; Rimbert A; Le May C; Cariou B; Si-Tayeb K
STAR Protoc; 2022 Dec; 3(4):101680. PubMed ID: 36115027
[TBL] [Abstract][Full Text] [Related]
26. Genetic correction of concurrent α- and β-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology.
Li L; Yi H; Liu Z; Long P; Pan T; Huang Y; Li Y; Li Q; Ma Y
Stem Cell Res Ther; 2022 Mar; 13(1):102. PubMed ID: 35255977
[TBL] [Abstract][Full Text] [Related]
27. A Rapid Pipeline to Model Rare Neurodevelopmental Disorders with Simultaneous CRISPR/Cas9 Gene Editing.
Bell S; Peng H; Crapper L; Kolobova I; Maussion G; Vasuta C; Yerko V; Wong TP; Ernst C
Stem Cells Transl Med; 2017 Mar; 6(3):886-896. PubMed ID: 28170165
[TBL] [Abstract][Full Text] [Related]
28. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
Yumlu S; Bashir S; Stumm J; Kühn R
Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
[TBL] [Abstract][Full Text] [Related]
29. Purification of Pluripotent Stem Cell-Derived Cardiomyocytes Using CRISPR/Cas9-Mediated Integration of Fluorescent Reporters.
Galdos FX; Darsha AK; Paige SL; Wu SM
Methods Mol Biol; 2021; 2158():223-240. PubMed ID: 32857377
[TBL] [Abstract][Full Text] [Related]
30. Generation of a tdTomato-GAD67 reporter human epilepsia mutation induced pluripotent stem cell line, USTCi001-A-2, using CRISPR/Cas9 editing.
Zhao H; He L; Huang H; Li S; Cheng N; Tang F; Han X; Lin Z; Huang R; Zhou P; Deng S; Huang J; Li Z
Stem Cell Res; 2020 Oct; 48():102003. PubMed ID: 32977294
[TBL] [Abstract][Full Text] [Related]
31. Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human iPSCs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant.
Que Z; Olivero-Acosta MI; Zhang J; Eaton M; Tukker AM; Chen X; Wu J; Xie J; Xiao T; Wettschurack K; Yunis L; Shafer JM; Schaber JA; Rochet JC; Bowman AB; Yuan C; Huang Z; Hu CD; Trader DJ; Skarnes WC; Yang Y
J Neurosci; 2021 Dec; 41(49):10194-10208. PubMed ID: 34716231
[TBL] [Abstract][Full Text] [Related]
32. Generation of a GLA knock-out human-induced pluripotent stem cell line, KSBCi002-A-1, using CRISPR/Cas9.
Kim YK; Yu JH; Min SH; Park SW
Stem Cell Res; 2020 Jan; 42():101676. PubMed ID: 31841972
[TBL] [Abstract][Full Text] [Related]
33. Generation of the induced human pluripotent stem cell lines CSSi009-A from a patient with a GNB5 pathogenic variant, and CSSi010-A from a CRISPR/Cas9 engineered GNB5 knock-out human cell line.
Malerba N; Benzoni P; Squeo GM; Milanesi R; Giannetti F; Sadleir LG; Poke G; Augello B; Croce AI; Barbuti A; Merla G
Stem Cell Res; 2019 Oct; 40():101547. PubMed ID: 31479876
[TBL] [Abstract][Full Text] [Related]
34. Generation of corrected hiPSC clones from a Cornelia de Lange Syndrome (CdLS) patient through CRISPR-Cas-based technology.
Umbach A; Maule G; Kheir E; Cutarelli A; Foglia M; Guarrera L; Fava LL; Conti L; Garattini E; Terao M; Cereseto A
Stem Cell Res Ther; 2022 Sep; 13(1):440. PubMed ID: 36056433
[TBL] [Abstract][Full Text] [Related]
35. Use of CRISPR/Cas ribonucleoproteins for high throughput gene editing of induced pluripotent stem cells.
Wang Q; Chear S; Wing K; Stellon D; Nguyen Tran MT; Talbot J; Pébay A; Hewitt AW; Cook AL
Methods; 2021 Oct; 194():18-29. PubMed ID: 33607266
[TBL] [Abstract][Full Text] [Related]
36. Generation of an NANS homozygous knockout human induced pluripotent stem cell line by the insertion of GFP-P2A-Puro via CRISPR/Cas9 editing.
Bu Q; Zhang H; Liu Q; Dai Y; Wei Q; Xue A; Huang Y; Zhong K; Huang Y; Gao H; Cen X
Stem Cell Res; 2020 Dec; 49():102052. PubMed ID: 33130469
[TBL] [Abstract][Full Text] [Related]
37. Generation of a CAG-EGFP tagged cell line (KSCBi017-A-2) from human induced pluripotent stem cells using CRISPR/Cas9.
Han HW; Im YS; Kim YO; Kwak S; Cho SJ
Stem Cell Res; 2024 Mar; 75():103303. PubMed ID: 38211411
[TBL] [Abstract][Full Text] [Related]
38. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
[TBL] [Abstract][Full Text] [Related]
39. Simplified Footprint-Free Cas9/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells.
Kondrashov A; Duc Hoang M; Smith JGW; Bhagwan JR; Duncan G; Mosqueira D; Munoz MB; Vo NTN; Denning C
Stem Cells Dev; 2018 Mar; 27(6):391-404. PubMed ID: 29402189
[TBL] [Abstract][Full Text] [Related]
40. Generation of miR-15a/16-1 cluster-deficient human induced pluripotent stem cell line (DMBi001-A-2) using CRISPR/Cas9 gene editing.
Stępniewski J; Jeż M; Dulak J
Stem Cell Res; 2023 Apr; 68():103046. PubMed ID: 36801567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
